Literature DB >> 33471897

De-coding Group 3 medulloblastoma biology with noncoding RNA.

Phedias Diamandis1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33471897      PMCID: PMC8041332          DOI: 10.1093/neuonc/noab010

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

Review 1.  Unique features of long non-coding RNA biogenesis and function.

Authors:  Jeffrey J Quinn; Howard Y Chang
Journal:  Nat Rev Genet       Date:  2016-01       Impact factor: 53.242

2.  Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Authors:  Patrick L Iversen; Vikram Arora; A J Acker; David H Mason; Gayathri R Devi
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

3.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.

Authors:  Paul A Northcott; David J H Shih; John Peacock; Livia Garzia; A Sorana Morrissy; Thomas Zichner; Adrian M Stütz; Andrey Korshunov; Jüri Reimand; Steven E Schumacher; Rameen Beroukhim; David W Ellison; Christian R Marshall; Anath C Lionel; Stephen Mack; Adrian Dubuc; Yuan Yao; Vijay Ramaswamy; Betty Luu; Adi Rolider; Florence M G Cavalli; Xin Wang; Marc Remke; Xiaochong Wu; Readman Y B Chiu; Andy Chu; Eric Chuah; Richard D Corbett; Gemma R Hoad; Shaun D Jackman; Yisu Li; Allan Lo; Karen L Mungall; Ka Ming Nip; Jenny Q Qian; Anthony G J Raymond; Nina T Thiessen; Richard J Varhol; Inanc Birol; Richard A Moore; Andrew J Mungall; Robert Holt; Daisuke Kawauchi; Martine F Roussel; Marcel Kool; David T W Jones; Hendrick Witt; Africa Fernandez-L; Anna M Kenney; Robert J Wechsler-Reya; Peter Dirks; Tzvi Aviv; Wieslawa A Grajkowska; Marta Perek-Polnik; Christine C Haberler; Olivier Delattre; Stéphanie S Reynaud; François F Doz; Sarah S Pernet-Fattet; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Wolfram Scheurlen; Charles G Eberhart; Michelle Fèvre-Montange; Anne Jouvet; Ian F Pollack; Xing Fan; Karin M Muraszko; G Yancey Gillespie; Concezio Di Rocco; Luca Massimi; Erna M C Michiels; Nanne K Kloosterhof; Pim J French; Johan M Kros; James M Olson; Richard G Ellenbogen; Karel Zitterbart; Leos Kren; Reid C Thompson; Michael K Cooper; Boleslaw Lach; Roger E McLendon; Darell D Bigner; Adam Fontebasso; Steffen Albrecht; Nada Jabado; Janet C Lindsey; Simon Bailey; Nalin Gupta; William A Weiss; László Bognár; Almos Klekner; Timothy E Van Meter; Toshihiro Kumabe; Teiji Tominaga; Samer K Elbabaa; Jeffrey R Leonard; Joshua B Rubin; Linda M Liau; Erwin G Van Meir; Maryam Fouladi; Hideo Nakamura; Giuseppe Cinalli; Miklós Garami; Peter Hauser; Ali G Saad; Achille Iolascon; Shin Jung; Carlos G Carlotti; Rajeev Vibhakar; Young Shin Ra; Shenandoah Robinson; Massimo Zollo; Claudia C Faria; Jennifer A Chan; Michael L Levy; Poul H B Sorensen; Matthew Meyerson; Scott L Pomeroy; Yoon-Jae Cho; Gary D Bader; Uri Tabori; Cynthia E Hawkins; Eric Bouffet; Stephen W Scherer; James T Rutka; David Malkin; Steven C Clifford; Steven J M Jones; Jan O Korbel; Stefan M Pfister; Marco A Marra; Michael D Taylor
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

4.  BET inhibitor resistance emerges from leukaemia stem cells.

Authors:  Chun Yew Fong; Omer Gilan; Enid Y N Lam; Alan F Rubin; Sarah Ftouni; Dean Tyler; Kym Stanley; Devbarna Sinha; Paul Yeh; Jessica Morison; George Giotopoulos; Dave Lugo; Philip Jeffrey; Stanley Chun-Wei Lee; Christopher Carpenter; Richard Gregory; Robert G Ramsay; Steven W Lane; Omar Abdel-Wahab; Tony Kouzarides; Ricky W Johnstone; Sarah-Jane Dawson; Brian J P Huntly; Rab K Prinjha; Anthony T Papenfuss; Mark A Dawson
Journal:  Nature       Date:  2015-09-14       Impact factor: 49.962

5.  Active medulloblastoma enhancers reveal subgroup-specific cellular origins.

Authors:  Charles Y Lin; Serap Erkek; Yiai Tong; Linlin Yin; Alexander J Federation; Marc Zapatka; Parthiv Haldipur; Daisuke Kawauchi; Thomas Risch; Hans-Jörg Warnatz; Barbara C Worst; Bensheng Ju; Brent A Orr; Rhamy Zeid; Donald R Polaski; Maia Segura-Wang; Sebastian M Waszak; David T W Jones; Marcel Kool; Volker Hovestadt; Ivo Buchhalter; Laura Sieber; Pascal Johann; Lukas Chavez; Stefan Gröschel; Marina Ryzhova; Andrey Korshunov; Wenbiao Chen; Victor V Chizhikov; Kathleen J Millen; Vyacheslav Amstislavskiy; Hans Lehrach; Marie-Laure Yaspo; Roland Eils; Peter Lichter; Jan O Korbel; Stefan M Pfister; James E Bradner; Paul A Northcott
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

6.  Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

Authors:  Sara Bolin; Anna Borgenvik; Camilla U Persson; Anders Sundström; Jun Qi; James E Bradner; William A Weiss; Yoon-Jae Cho; Holger Weishaupt; Fredrik J Swartling
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

7.  Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

Authors:  Xiangpeng Dai; Wenjian Gan; Xiaoning Li; Shangqian Wang; Wei Zhang; Ling Huang; Shengwu Liu; Qing Zhong; Jianping Guo; Jinfang Zhang; Ting Chen; Kouhei Shimizu; Francisco Beca; Mirjam Blattner; Divya Vasudevan; Dennis L Buckley; Jun Qi; Lorenz Buser; Pengda Liu; Hiroyuki Inuzuka; Andrew H Beck; Liewei Wang; Peter J Wild; Levi A Garraway; Mark A Rubin; Christopher E Barbieri; Kwok-Kin Wong; Senthil K Muthuswamy; Jiaoti Huang; Yu Chen; James E Bradner; Wenyi Wei
Journal:  Nat Med       Date:  2017-08-14       Impact factor: 53.440

8.  Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.

Authors:  Pratiti Bandopadhayay; Federica Piccioni; Ryan O'Rourke; Patricia Ho; Elizabeth M Gonzalez; Graham Buchan; Kenin Qian; Gabrielle Gionet; Emily Girard; Margo Coxon; Matthew G Rees; Lisa Brenan; Frank Dubois; Ofer Shapira; Noah F Greenwald; Melanie Pages; Amanda Balboni Iniguez; Brenton R Paolella; Alice Meng; Claire Sinai; Giovanni Roti; Neekesh V Dharia; Amanda Creech; Benjamin Tanenbaum; Prasidda Khadka; Adam Tracy; Hong L Tiv; Andrew L Hong; Shannon Coy; Rumana Rashid; Jia-Ren Lin; Glenn S Cowley; Fred C Lam; Amy Goodale; Yenarae Lee; Kathleen Schoolcraft; Francisca Vazquez; William C Hahn; Aviad Tsherniak; James E Bradner; Michael B Yaffe; Till Milde; Stefan M Pfister; Jun Qi; Monica Schenone; Steven A Carr; Keith L Ligon; Mark W Kieran; Sandro Santagata; James M Olson; Prafulla C Gokhale; Jacob D Jaffe; David E Root; Kimberly Stegmaier; Cory M Johannessen; Rameen Beroukhim
Journal:  Nat Commun       Date:  2019-06-03       Impact factor: 14.919

Review 9.  Noncoding RNAs in cancer therapy resistance and targeted drug development.

Authors:  Wen-Tao Wang; Cai Han; Yu-Meng Sun; Tian-Qi Chen; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2019-06-07       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.